Glassman Wealth Services’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14
| Closed | -$303 | – | 1504 |
|
|
2023
Q4 | $303 | Sell |
14
-63
| -82% | -$1.36K | ﹤0.01% | 1820 |
|
|
2023
Q3 | $1.59K | Buy |
+77
| New | +$1.59K | ﹤0.01% | 1406 |
|
|
2022
Q1 | – | Sell |
-301
| Closed | -$13K | – | 1904 |
|
|
2021
Q4 | $13K | Buy |
301
+252
| +514% | +$10.9K | ﹤0.01% | 722 |
|
|
2021
Q3 | $2K | Sell |
49
-78
| -61% | -$3.18K | ﹤0.01% | 1214 |
|
|
2021
Q2 | $7K | Buy |
127
+2
| +2% | +$110 | ﹤0.01% | 843 |
|
|
2021
Q1 | $9K | Hold |
125
| – | – | ﹤0.01% | 743 |
|
|
2020
Q4 | $11K | Buy |
125
+80
| +178% | +$7.04K | ﹤0.01% | 692 |
|
|
2020
Q3 | $3K | Hold |
45
| – | – | ﹤0.01% | 921 |
|
|
2020
Q2 | $2K | Buy |
45
+22
| +96% | +$978 | ﹤0.01% | 892 |
|
|
2020
Q1 | $1K | Buy |
23
+20
| +667% | +$870 | ﹤0.01% | 975 |
|
|
2019
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1441 |
|
|
2019
Q3 | – | Sell |
-9
| Closed | -$2K | – | 1335 |
|
|
2019
Q2 | $2K | Buy |
+9
| New | +$2K | ﹤0.01% | 744 |
|